Literature DB >> 19115969

Early immunological predictors of neurodevelopmental outcomes in HIV-infected children.

Jutarat Mekmullica1, Pim Brouwers, Manhattan Charurat, Mary Paul, William Shearer, Hermann Mendez, Clemente Diaz, Jennifer S Read, Prosanta Mondal, Renee Smith, Kenneth McIntosh.   

Abstract

BACKGROUND: A previous analysis of children infected with human immunodeficiency virus (HIV) in the Women and Infants Transmission Study showed a strong correlation between low activated CD8(+) T lymphocytes in the first 2 months of life and good immunological prognosis. We sought to extend these observations to neurodevelopmental prognosis.
METHODS: Ninety-eight HIV-infected children born before 1994 with flow cytometric data from the first 2 months of life and adequate neurodevelopmental testing through age 30 months were studied. Children were divided into those with low (<or=5% CD8(+)HLA-DR(+) cells or <or=25% CD8(+)CD38(+) cells) or high (>5% CD8(+)HLA-DR(+) cells or >25% CD8(+)CD38(+) cells) immune activation at 1 and/or 2 months of age. Analysis was performed using survival analysis, Cox's proportional hazard regression, and longitudinal regression models.
RESULTS: Absence of immune activation, measured as <or=5% CD8(+)HLA-DR(+) cells, was strongly associated with better performance on the psychomotor developmental index of the Bayley scales of infant development through the third year of life. This association persisted after adjustment for CD4 cell count, viral load, and progression to acquired immunodeficiency syndrome (P= .005). An association with the mental development index was also present (P= .048). Significant association between neurodevelopmental outcomes and <or=25% CD8(+)CD38(+) cells was not seen.
CONCLUSIONS: In this prospective cohort study of HIV-infected children, there was a significant favorable association of low immune activation in peripheral T cells at age 1 or 2 months, measured by a low percentage of CD8(+)HLA-DR(+) cells, with subsequent psychomotor and mental development. This association was independent of other indices of severity and progression of HIV infection.

Entities:  

Mesh:

Year:  2009        PMID: 19115969      PMCID: PMC3671733          DOI: 10.1086/595885

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion.

Authors:  Thomas D Marcotte; Reena Deutsch; J Allen McCutchan; David J Moore; Scott Letendre; Ronald J Ellis; Mark R Wallace; Robert K Heaton; Igor Grant
Journal:  Arch Neurol       Date:  2003-10

2.  Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets.

Authors:  T W McCloskey; N Kohn; M Lesser; S Bakshi; S Pahwa
Journal:  Cytometry       Date:  2001-06-15

3.  Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.

Authors:  M E Paul; W T Shearer; C A Kozinetz; D E Lewis
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

4.  CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.

Authors:  Gayle G Sherman; Lesley E Scott; Jacqueline S Galpin; Louise Kuhn; Caroline T Tiemessen; Karen Simmank; Stephen Meddows-Taylor; Tamara M Meyers
Journal:  Pediatr Res       Date:  2002-06       Impact factor: 3.756

5.  Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group.

Authors:  C Chase; J Ware; J Hittelman; I Blasini; R Smith; A Llorente; E Anisfeld; C Diaz; M G Fowler; J Moye; L I Kaligh
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

6.  Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group.

Authors:  R Smith; K Malee; M Charurat; L Magder; C Mellins; C Macmillan; J Hittleman; T Lasky; A Llorente; J Moye
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

7.  Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women.

Authors:  C Macmillan; L S Magder; P Brouwers; C Chase; J Hittelman; T Lasky; K Malee; C A Mellins; J Velez-Borras
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease.

Authors:  P Brouwers; L Civitello; C DeCarli; P Wolters; S Sei
Journal:  J Neurovirol       Date:  2000-10       Impact factor: 2.643

9.  Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Authors:  Silvia Sánchez-Ramón; José Ma Bellón; Salvador Resino; Carmen Cantó-Nogués; Dolores Gurbindo; José-Tomás Ramos; Ma Angeles Muñoz-Fernández
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

10.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Authors:  William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

View more
  12 in total

1.  Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence.

Authors:  Renee Smith; Miriam Chernoff; Paige L Williams; Kathleen M Malee; Patricia A Sirois; Betsy Kammerer; Megan Wilkins; Sharon Nichols; Claude Mellins; Ann Usitalo; Patricia Garvie; Richard Rutstein
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

2.  T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children.

Authors:  Suad Kapetanovic; Lisa Aaron; Grace Montepiedra; Sandra K Burchett; Andrea Kovacs
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

3.  Reproductive health decision-making in perinatally HIV-infected adolescents and young adults.

Authors:  Cynthia Fair; Lori Wiener; Sima Zadeh; Jamie Albright; Claude Ann Mellins; Michael Mancilla; Vicki Tepper; Connie Trexler; Julia Purdy; Janet Osherow; Susan Lovelace; Suad Kapetanovic
Journal:  Matern Child Health J       Date:  2013-07

4.  Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure.

Authors:  Kathleen M Malee; Katherine Tassiopoulos; Yanling Huo; George Siberry; Paige L Williams; Rohan Hazra; Renee A Smith; Susannah M Allison; Patricia A Garvie; Betsy Kammerer; Suad Kapetanovic; Sharon Nichols; Russell Van Dyke; George R Seage; Claude A Mellins
Journal:  AIDS Care       Date:  2011-12

Review 5.  CNS Impact of Perinatal HIV Infection and Early Treatment: the Need for Behavioral Rehabilitative Interventions Along with Medical Treatment and Care.

Authors:  Michael J Boivin; Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

6.  The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.

Authors:  Suad Kapetanovic; Lisa Aaron; Grace Montepiedra; Patricia A Sirois; James M Oleske; Kathleen Malee; Deborah A Pearson; Sharon L Nichols; Patricia A Garvie; John Farley; Molly L Nozyce; Mark Mintz; Paige L Williams
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

7.  Nutritional and Immunological Correlates of Memory and Neurocognitive Development Among HIV-Infected Children Living in Kayunga, Uganda.

Authors:  Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Alla Sikorskii; Nikita Jambulingam; Noelline Nakasujja; Robert Opoka; Judith Bass; Michael Boivin
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-15       Impact factor: 3.731

Review 8.  Immune activation and paediatric HIV-1 disease outcome.

Authors:  Julia M Roider; Maximilian Muenchhoff; Philip J R Goulder
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

9.  Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children.

Authors:  Ravi Tandon; Maria T M Giret; Devi Sengupta; Vanessa A York; Andrew A Wiznia; Michael G Rosenberg; Esper G Kallas; Lishomwa C Ndhlovu; Douglas F Nixon
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

10.  Psychiatric Comorbidities in Pediatric Inpatients With Human Immunodeficiency Virus Infection and Impact on Hospital Course: Inputs From a Case-Control Inpatient Study.

Authors:  Caroline C Dias; Victoria Ayala; Fartun A Aliduux; Sayeda A Basith; Albulena Sejdiu; Miles M Nakaska; Sabiha Akter; Keerthika Mathialagan; Pradipta Majumder
Journal:  Cureus       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.